Arthroplasty
AAOS2018: Additional compression pump to aspirin for thromboprophylaxis after TJA unnecessary
80 patients scheduled for total joint arthroplasty were randomized to thromboprophylaxis with either combined aspirin and a pneumatic compression pump, or aspirin alone. Patients were assessed for compliance with allocated intervention and for the incidence of venous thromboembolism within the first 90 days postoperatively. Only 25% of patients given a mobile compression pump were compliant with prescribed use. In addition, the incidence of VTE did not significantly differ between the two groups.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
